Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Journal of Family Issues|July 11, 2026
Mexican American Fathers in Research: Understanding Perceptions, Barriers, and Contributors to ParticipationAnthony Muñoz-Gauna, Maria Flores Gallegos, Melissa S Fineman, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 12, 2005
Properties of pramlintide and insulin upon mixingChristian Weyer, Mark S Fineman, Susan Strobel, et al.
JAMA Ophthalmology|February 26, 2016
Topical Dorzolamide-Timolol With Intravitreous Anti-Vascular Endothelial Growth Factor for Neovascular Age-Related Macular DegenerationJayanth Sridhar, Jason Hsu, Abtin Shahlaee, et al.
Diabetes Care|October 27, 2004
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetesJohn B Buse, Robert R Henry, Jenny Han, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|October 25, 2007
Pegaptanib for choroidal neovascularization in treatment-naïve exudative age-related macular degenerationJustis P Ehlers, David R Fintak, Omesh P Gupta, et al.
Retina (Philadelphia, Pa.)|May 9, 2008
Short-term outcomes of 25-gauge vitrectomy with silicone oil for repair of complicated retinal detachmentChirag P Shah, Allen C Ho, Carl D Regillo, et al.
American Journal of Ophthalmology|December 11, 2012
Serous macular detachment in Waldenström macroglobulinemia: a report of four casesPaul S Baker, Sunir J Garg, Mitchell S Fineman, et al.
Journal of Vitreoretinal Diseases|August 16, 2024
Indications and Outcomes of Laser Retinopexy in Eyes With High-Risk Lattice DegenerationAdina S Kazan, Raziyeh Mahmoudzadeh, Mirataollah Salabati, et al.
Diabetes Care|April 28, 2005
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylureaDavid M Kendall, Matthew C Riddle, Julio Rosenstock, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|May 14, 2005
Adjunctive therapy with pramlintide lowers HbA1c without concomitant weight gain and increased risk of severe hypoglycemia in patients with type 1 diabetes approaching glycemic targetsR Ratner, F Whitehouse, M S Fineman, et al.
Pageof 9